Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients

A Multicenter Study

Francesco Locatelli, Simeone Andrulli, Sara Maria Viganò, Massimo Concetti, Sauro Urbini, Franca Giacchino, Roberto Broccoli, Filippo Aucella, Maria Cossu, Paolo Conti, Laura Fattori, Giorgio Punzo, Daniela Angelini, Marco Peruzzini, Salvatore DI Giulio, Marta Piroddi, Francesco Galli, Lucia Del Vecchio

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Oxidative stress has been related to hypo-response to erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. The aim of this study was to verify whether vitamin E (ViE) on a synthetic polysulfone dialyzer can improve ESA responsiveness. Methods: This controlled, multicenter study involved 93 HD patients on stable ESA therapy, who were randomized to either ViE-coated polysulfone dialyzer or to a low-flux synthetic dialyzer. The primary outcome measure was the change in ESA resistance index (ERI) from baseline. Results: Mean ERI decreased in the ViE group by 1.45 IU/kg∗g/dl and increased in the control group by 0.53 IU/kg∗g/dl, with a mean difference of 1.98 IU/kg∗g/dl (p = 0.001 after adjusting for baseline ERI, as foreseen by the study protocol). Baseline ERI was inversely related to its changes during follow-up only in the control group (R2 = 0.29). Conclusions: The ViE dialyzer can improve ESA response in HD patients. Changes in ERI during follow-up are independent from baseline ERI only in the ViE group. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=453442.

Original languageEnglish
Pages (from-to)338-345
Number of pages8
JournalBlood Purification
Volume43
Issue number4
DOIs
Publication statusPublished - Apr 1 2017
Externally publishedYes

Fingerprint

Hematinics
Erythropoietin
Vitamin E
Multicenter Studies
Renal Dialysis
Membranes
Therapeutics
Control Groups
Oxidative Stress
Outcome Assessment (Health Care)

Keywords

  • Erythropoiesis-stimulating agent resistance
  • Erythropoiesis-stimulating agent responsiveness
  • Erythropoietin
  • Hemodialysis
  • Vitamin E

ASJC Scopus subject areas

  • Hematology
  • Nephrology

Cite this

Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients : A Multicenter Study. / Locatelli, Francesco; Andrulli, Simeone; Viganò, Sara Maria; Concetti, Massimo; Urbini, Sauro; Giacchino, Franca; Broccoli, Roberto; Aucella, Filippo; Cossu, Maria; Conti, Paolo; Fattori, Laura; Punzo, Giorgio; Angelini, Daniela; Peruzzini, Marco; DI Giulio, Salvatore; Piroddi, Marta; Galli, Francesco; Del Vecchio, Lucia.

In: Blood Purification, Vol. 43, No. 4, 01.04.2017, p. 338-345.

Research output: Contribution to journalArticle

Locatelli, F, Andrulli, S, Viganò, SM, Concetti, M, Urbini, S, Giacchino, F, Broccoli, R, Aucella, F, Cossu, M, Conti, P, Fattori, L, Punzo, G, Angelini, D, Peruzzini, M, DI Giulio, S, Piroddi, M, Galli, F & Del Vecchio, L 2017, 'Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study', Blood Purification, vol. 43, no. 4, pp. 338-345. https://doi.org/10.1159/000453442
Locatelli, Francesco ; Andrulli, Simeone ; Viganò, Sara Maria ; Concetti, Massimo ; Urbini, Sauro ; Giacchino, Franca ; Broccoli, Roberto ; Aucella, Filippo ; Cossu, Maria ; Conti, Paolo ; Fattori, Laura ; Punzo, Giorgio ; Angelini, Daniela ; Peruzzini, Marco ; DI Giulio, Salvatore ; Piroddi, Marta ; Galli, Francesco ; Del Vecchio, Lucia. / Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients : A Multicenter Study. In: Blood Purification. 2017 ; Vol. 43, No. 4. pp. 338-345.
@article{0d023bf247d149a4b1ca9205185e285a,
title = "Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study",
abstract = "Background: Oxidative stress has been related to hypo-response to erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. The aim of this study was to verify whether vitamin E (ViE) on a synthetic polysulfone dialyzer can improve ESA responsiveness. Methods: This controlled, multicenter study involved 93 HD patients on stable ESA therapy, who were randomized to either ViE-coated polysulfone dialyzer or to a low-flux synthetic dialyzer. The primary outcome measure was the change in ESA resistance index (ERI) from baseline. Results: Mean ERI decreased in the ViE group by 1.45 IU/kg∗g/dl and increased in the control group by 0.53 IU/kg∗g/dl, with a mean difference of 1.98 IU/kg∗g/dl (p = 0.001 after adjusting for baseline ERI, as foreseen by the study protocol). Baseline ERI was inversely related to its changes during follow-up only in the control group (R2 = 0.29). Conclusions: The ViE dialyzer can improve ESA response in HD patients. Changes in ERI during follow-up are independent from baseline ERI only in the ViE group. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=453442.",
keywords = "Erythropoiesis-stimulating agent resistance, Erythropoiesis-stimulating agent responsiveness, Erythropoietin, Hemodialysis, Vitamin E",
author = "Francesco Locatelli and Simeone Andrulli and Vigan{\`o}, {Sara Maria} and Massimo Concetti and Sauro Urbini and Franca Giacchino and Roberto Broccoli and Filippo Aucella and Maria Cossu and Paolo Conti and Laura Fattori and Giorgio Punzo and Daniela Angelini and Marco Peruzzini and {DI Giulio}, Salvatore and Marta Piroddi and Francesco Galli and {Del Vecchio}, Lucia",
year = "2017",
month = "4",
day = "1",
doi = "10.1159/000453442",
language = "English",
volume = "43",
pages = "338--345",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients

T2 - A Multicenter Study

AU - Locatelli, Francesco

AU - Andrulli, Simeone

AU - Viganò, Sara Maria

AU - Concetti, Massimo

AU - Urbini, Sauro

AU - Giacchino, Franca

AU - Broccoli, Roberto

AU - Aucella, Filippo

AU - Cossu, Maria

AU - Conti, Paolo

AU - Fattori, Laura

AU - Punzo, Giorgio

AU - Angelini, Daniela

AU - Peruzzini, Marco

AU - DI Giulio, Salvatore

AU - Piroddi, Marta

AU - Galli, Francesco

AU - Del Vecchio, Lucia

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Background: Oxidative stress has been related to hypo-response to erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. The aim of this study was to verify whether vitamin E (ViE) on a synthetic polysulfone dialyzer can improve ESA responsiveness. Methods: This controlled, multicenter study involved 93 HD patients on stable ESA therapy, who were randomized to either ViE-coated polysulfone dialyzer or to a low-flux synthetic dialyzer. The primary outcome measure was the change in ESA resistance index (ERI) from baseline. Results: Mean ERI decreased in the ViE group by 1.45 IU/kg∗g/dl and increased in the control group by 0.53 IU/kg∗g/dl, with a mean difference of 1.98 IU/kg∗g/dl (p = 0.001 after adjusting for baseline ERI, as foreseen by the study protocol). Baseline ERI was inversely related to its changes during follow-up only in the control group (R2 = 0.29). Conclusions: The ViE dialyzer can improve ESA response in HD patients. Changes in ERI during follow-up are independent from baseline ERI only in the ViE group. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=453442.

AB - Background: Oxidative stress has been related to hypo-response to erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. The aim of this study was to verify whether vitamin E (ViE) on a synthetic polysulfone dialyzer can improve ESA responsiveness. Methods: This controlled, multicenter study involved 93 HD patients on stable ESA therapy, who were randomized to either ViE-coated polysulfone dialyzer or to a low-flux synthetic dialyzer. The primary outcome measure was the change in ESA resistance index (ERI) from baseline. Results: Mean ERI decreased in the ViE group by 1.45 IU/kg∗g/dl and increased in the control group by 0.53 IU/kg∗g/dl, with a mean difference of 1.98 IU/kg∗g/dl (p = 0.001 after adjusting for baseline ERI, as foreseen by the study protocol). Baseline ERI was inversely related to its changes during follow-up only in the control group (R2 = 0.29). Conclusions: The ViE dialyzer can improve ESA response in HD patients. Changes in ERI during follow-up are independent from baseline ERI only in the ViE group. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=453442.

KW - Erythropoiesis-stimulating agent resistance

KW - Erythropoiesis-stimulating agent responsiveness

KW - Erythropoietin

KW - Hemodialysis

KW - Vitamin E

UR - http://www.scopus.com/inward/record.url?scp=85014090018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014090018&partnerID=8YFLogxK

U2 - 10.1159/000453442

DO - 10.1159/000453442

M3 - Article

VL - 43

SP - 338

EP - 345

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 4

ER -